VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $416,150 | -35.7% | 96,331 | -1.9% | 0.05% | -31.9% |
| Q2 2023 | $646,921 | -5.5% | 98,167 | -2.7% | 0.07% | -14.3% |
| Q1 2023 | $684,724 | -8.1% | 100,843 | 0.0% | 0.08% | -10.6% |
| Q4 2022 | $745,230 | -25.2% | 100,843 | 0.0% | 0.09% | -45.0% |
| Q3 2022 | $996,000 | -9.4% | 100,843 | 0.0% | 0.17% | -36.2% |
| Q2 2022 | $1,099,000 | -1.3% | 100,843 | +2.4% | 0.27% | +18.6% |
| Q1 2022 | $1,114,000 | -71.8% | 98,480 | -60.9% | 0.23% | -44.2% |
| Q4 2021 | $3,956,000 | +17.7% | 252,152 | +28.6% | 0.40% | -44.7% |
| Q3 2021 | $3,360,000 | -21.4% | 196,026 | -1.4% | 0.73% | -4.6% |
| Q2 2021 | $4,276,000 | +58.4% | 198,812 | +10.6% | 0.77% | +56.1% |
| Q1 2021 | $2,699,000 | +23.4% | 179,689 | +7.9% | 0.49% | +5.4% |
| Q4 2020 | $2,188,000 | +43.4% | 166,518 | +5.4% | 0.47% | +15.6% |
| Q3 2020 | $1,526,000 | -14.3% | 158,004 | +1.6% | 0.40% | -10.6% |
| Q2 2020 | $1,780,000 | +18.1% | 155,561 | +7.0% | 0.45% | -2.4% |
| Q1 2020 | $1,507,000 | -36.8% | 145,426 | 0.0% | 0.46% | +3.6% |
| Q4 2019 | $2,386,000 | +272.8% | 145,426 | +201.7% | 0.45% | +219.3% |
| Q3 2019 | $640,000 | +123.0% | 48,207 | +136.9% | 0.14% | +133.3% |
| Q2 2019 | $287,000 | -71.8% | 20,353 | -63.2% | 0.06% | -72.1% |
| Q1 2019 | $1,018,000 | -42.9% | 55,333 | -18.9% | 0.22% | -49.3% |
| Q4 2018 | $1,783,000 | -7.3% | 68,243 | -18.6% | 0.42% | +12.2% |
| Q3 2018 | $1,924,000 | +58.0% | 83,843 | +31.1% | 0.38% | +51.8% |
| Q2 2018 | $1,218,000 | +30.1% | 63,943 | +8.9% | 0.25% | +6.9% |
| Q4 2016 | $936,000 | -5.3% | 58,705 | -1.2% | 0.23% | -5.7% |
| Q3 2016 | $988,000 | +98700.0% | 59,405 | +83569.0% | 0.25% | – |
| Q1 2014 | $1,000 | -50.0% | 71 | -66.2% | 0.00% | – |
| Q4 2013 | $2,000 | +100.0% | 210 | +118.8% | 0.00% | – |
| Q3 2013 | $1,000 | – | 96 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |